1. AbbVie to License I-Mab's Lemzoparlimab (TJC4) for ~$2B

Published: Sept 04, 2020 | Tags: AbbVie, License, I-Mab, Lemzoparlimab, (TJC4), ~$2B

2. Kite and HiFiBiO Therapeutics Collaborate to Develop Antibodies Targeting Acute Myeloid Leukemia

Published: Sept 03, 2020 | Tags: Kite, HiFiBiO Therapeutics, Collaborate, Antibodies, Targeting, Acute Myeloid Leukemia

3. Abbott Initiates LIFE-BTK Trial to Evaluate the Esprit BTK Drug-Eluting Resorbable Scaffold

Published: Sept 03, 2020 | Tags: Abbott, Initiates, LIFE-BTK Trial, Evaluate, the Esprit BTK, Drug-Eluting Resorbable Scaffold

4. Innovent's Sulinno (biosimilar, adalimumab) Receives NMPA's Approval for Autoimmune Diseases

Published: Sept 03, 2020 | Tags: Innovent, Sulinno, (biosimilar, adalimumab, Receives, NMPA, Approval, Autoimmune Diseases

5. Roche Receives the US FDA's EUA for cobas SARS-CoV-2 and Influenza A/B Test

Published: Sept 04, 2020   | Tags: Roche, Receives, US, FDA, EUA, cobas SARS-CoV-2, Influenza A/B Test

6. Eli Lilly's Trulicity (dulaglutide) Receives the US FDA's Approval for Additional Doses to Treat Type 2 Diabetes

Published: Sept 03, 2020 | Tags: Eli Lilly, Trulicity, (dulaglutide), Receives, US, FDA, Approval, Additional Doses, Treat, Type 2 Diabetes

7. Bio-Thera Initiates P-I Study of BAT2206 Proposed Biosimilar to Stelara (ustekinumab)

Published: Sept 03, 2020 | Tags: Bio-Thera, Initiates, P-I, Study, BAT2206, Proposed Biosimilar, Stelara, (ustekinumab)

8. Bicycle Reports First Patient Dosing in P-IIa Study of BT1718 for MT1-MMP-Positive Squamous NSCLC

Published: Sept 02, 2020 | Tags: Bicycle, Reports, First Patient Dosing, P-IIa, Study,  BT1718

9. Baxter's Theranova Dialyzers Receives the US FDA's De Novo Authorization to Deliver HDx Therapy

Published: Sept 03, 2020 | Tags: Baxter, DE Novo, Authorization, FDA,    Receives, Theranova, Dialyzers, US

10. Janssen Halts the Development of Pimodivir for Influenza

Published: Sept 02, 2020 | Tags: Development, Halts, Influenza, Janssen, Pimodivir

11. Merck Signs a Second Oncology Collaboration with Highlight Therapeutics

Published: Sept 02, 2020 | Tags: Merck, Signs, Second, Oncology, Collaboration, Highlight, Therapeutics

12. Boehringer Ingelheim Collaborates with BiomX to Discover Microbiome-Based Biomarkers for Inflammatory Bowel Disease

Published: Sept 02, 2020 | Tags: BiomX, Boehringer Ingelheim, Collaborates, Discover, Inflammatory Bowel Disease, Microbiome-Based, Biomarkers

13. Sanofi And GSK Initiate P-I/II Study of COVID-19 Protein-Based Vaccine

Published: Sept 03, 2020 | Tags: COVID-19, GSK, Initiate, P-I/II, Protein Based, Vaccine, Sanofi, Study

14. Idorsia Transfers its Agreement with ReveraGen to Santhera for Vamorolone

Published: Sept 02, 2020 | Tags: Agreement, Idorsia, ReveraGen, Santhera, Transfers, Vamorolone

15. BMS' Onureg (azacitidine) Receives the US FDA's Approval as Continued Treatment for Acute Myeloid Leukemia

Published: Sept 02, 2020 | Tags: Azacytidine, Acute Myeloid Leukemia, Approval, BMS, Continued, Treatment, FDA, Onureg, Receives, US

16. AstraZeneca's Imfinzi (durvalumab) Receives EC's Approval as 1L Treatment for Extensive-Stage Small Cell Lung Cancer

Published: Sept 01, 2020 | Tags: durvalumab, ES-SCLC, AstraZeneca, Extensive-Stage, Small Cell Lung Cancer, Imfinzi, Receives

17. Nestlé to Acquire Aimmune Therapeutics for $2.6B

Published: Aug 31, 2020 | Tags: $2.6B, Acquire, Aimmune Therapeutics, Nestlé

18. Medtronic's MiniMed 770G Insulin Pump System with Smartphone Connectivity Receives the US FDA's Approval for Patients with Type 1 Diabetes

Published: Sept 01, 2020 | Tags:  Approval, Connectivity, FDA, Medtronic, Minimed, 770g, Insulin Pump, System, Patients, Receives, Smartphone, Type 1 Diabetes, US

19. Gilead Signs an Exclusive License Agreement with Jounce for Cancer Immunotherapies

Published: Sept 02, 2020 | Tags:  Exclusive, Cancer, Immunotherapies, Gilead, Jounce, License, Agreement

20. Roche's cobas HIV-1/HIV-2 Qualitative Test Receives the US FDA's Approval to Detect HIV Infection

Published: Sept 02, 2020 | Tags: approval cobas 6800/8800 Systems FDA HIV-1/HIV-2 Qualitative Test receives Roche

21. Roche's Enspryng (satralizumab) Receives Health Canada Approval for Neuromyelitis Optica Spectrum Disorder

Published: Sept 02, 2020| Tags: Authorizes, Ensprying, Health Canada, Neuromyelitis Optica Spectrum Disorder, Roche

22. AstraZeneca Expands Supply Agreement with Oxford Biomedica for AZD1222 to Combat COVID-19

Published: Aug 31, 2020| Tags: AstraZeneca, AZD1222, COVID-19, Expands, Oxford BioMedica, Supply, Agreement

23. GSK and VIR Biotechnology Initiate P-II/III COMET-ICE Study of VIR-7831 Against COVID-19

Published: Aug 31, 2020 | Tags: Against, COVID-19, GSK, Initiate, P-II/III, COMET-ICE, Study, Vir Biotechnology, VIR-7831

24. AstraZeneca Expands the Development of AZD1222 into P-III Study in the US Across All Adult Age Groups

Published: Aug 31, 2020 | Tags: Across, Age, Adult, AstraZeneca, AZD1222, Development, Expands, Groups, P-III, US

25. Johnson & Johnson Collaborates with the Government of Canada to Supply its Ad26.COV2.S for COVID-19

Published: Aug 31, 2020 | Tags: Ad26.COV2.S, Collaborates, Government of Canada, Johnson & Johnson, Supply

26. Ionis to Acquire Remaining Stake in Akcea Therapeutics for $18.5/share

Published: Aug 31, 2020 | Tags: $18.5/share, Acquire, Akcea Therapeutics, Ionis, Remaining, Stake

27. Mylan and Biocon Launch Semglee (insulin glargine injection) as Vials and Pre-Filled Pen in the US

Published: Aug 31, 2020 | Tags: Insulin Glargine injection, Biocon, Launch, Mylan, Pre-Filled, Pen, Semglee, US Vials

28. Cadila Launches Cadalimab (biosimilar, adalimumab) in India

Published: Aug 31, 2020 | Tags: Adalimumab, Biosimilar, Cadalimab, Cadila, India, Launches

29. AstraZeneca Reports Results of Farxiga (dapagliflozin) in P-III DAPA-CKD Trial for Patients With and Without Type-2 Diabetes

Published: Aug 31, 2020 | Tags: Dapagliflozin, AstraZeneca, DAPA-CKD, Trial, Farxiga, P-III, Reports, Results, Type-2 Diabetes

30. World's First App-Based Nicotine Addiction Treatment Receives the MHLW's Approval in Japan

Published: Aug 29, 2020 | Tags: Approved, Asia, CO Checker, CureApp, Digital Therapeutic, First, Prescription, Japan, Nicotine Addiction, Treatment, App, Receives, Regulatory, Approval

31. Novartis Reports Results of LNP023 in P-II Study for Paroxysmal Nocturnal Hemoglobinuria

Published: Aug 31, 2020  | Tags: LNP023, Novartis, P-II, Paroxysmal Nocturnal Hemoglobinuria, Reports Results,